Items Tagged ‘Stage III non-small cell lung cancer’

May 30th, 2017

Imfinzi Improves Outcomes for Patients With Stage III Non Small Cell Lung Cancer


Positive results for the PACIFIC clinical trial evaluating the novel precision medicine, Imfinzi (durvalumab) as sequential treatment in patients with Stage III non-small cell lung cancer (NSCLC) who had not progressed following standard platinum-based chemotherapy concurrent with radiation therapy have been reported.1 Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, […]

View full entry

Tags: durvalumab, Imfinzi, Lung Cancer - Non-Small Cell, News, nsclc, precision medicine, Stage III non-small cell lung cancer